Tempest Therapeutics, Inc. (TPST)
NASDAQ·Healthcare·Biotechnology
$1.28
+2.40%
Mkt Cap $10.61M
No analyst coverage available
We don't have analyst ratings or price target data for Tempest Therapeutics, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.